Granules India surges on plan to focus on R&D and formulations

15 Jul 2015 Evaluate

Granules India is currently trading at Rs 93.70, up by 3.75 points or 4.17% from its previous closing of Rs. 89.95 on the BSE.

The scrip opened at Rs. 90.60 and has touched a high and low of Rs 93.95 and Rs. 90.60 respectively. So far 918527 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 104.00 on 15-Apr-2015 and a 52 week low of Rs. 54.27 on 15-Jul-2014.

Last one week high and low of the scrip stood at Rs. 93.95 and Rs. 80.05 respectively. The current market cap of the company is Rs. 1878.69 crore.

The promoters holding in the company stood at 48.59% while Institutions and Non-Institutions held 4.11% and 47.30% respectively.

Granules India is planning to focus on Research and Development (R&D) and formulations. Moreover, the company may look at acquiring companies having high technology in formulations manufacturing or with a sizable formulations portfolio. The company would like to make 1-2 acquisitions preferably in the US and in India if it could find a right company.

Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.

Granules India Share Price

593.90 -12.00 (-1.98%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.